Cargando…

Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer

INTRODUCTION: BRCA1 or BRCA2 germline mutations increase the risk of developing breast cancer. Tumour cells from germline mutation carriers have frequently lost the wild-type allele. This is predicted to result in genomic instability where cell survival depends upon dysfunctional checkpoint mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Birgisdottir, Valgerdur, Stefansson, Olafur A, Bodvarsdottir, Sigridur K, Hilmarsdottir, Holmfridur, Jonasson, Jon G, Eyfjord, Jorunn E
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779478/ https://www.ncbi.nlm.nih.gov/pubmed/16846527 http://dx.doi.org/10.1186/bcr1522

Ejemplares similares

Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriers
por: Aradottir, Margret, et al.
Publicado: (2014)

Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression
por: Stefansson, Olafur A, et al.
Publicado: (2011)

CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer
por: Stefansson, Olafur Andri, et al.
Publicado: (2011)

BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy
por: Stefansson, Olafur A, et al.
Publicado: (2019)

Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes
por: Stefansson, Olafur Andri, et al.
Publicado: (2009)

Correction: Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes
por: Stefansson, Olafur Andri, et al.
Publicado: (2009)

A DNA methylation‐based definition of biologically distinct breast cancer subtypes
por: Stefansson, Olafur A., et al.
Publicado: (2014)

BRCA2 Haploinsufficiency in Telomere Maintenance
por: Gunnarsdottir, Soffía R., et al.
Publicado: (2021)

CpG promoter hypo-methylation and up-regulation of microRNA-190b in hormone receptor-positive breast cancer
por: Frick, Elisabet, et al.
Publicado: (2019)

CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer
por: Stefansson, Olafur Andri, et al.
Publicado: (2017)

BRCA2 mutation carriers, reproductive factors and breast cancer risk
por: Tryggvadottir, Laufey, et al.
Publicado: (2003)

The Icelandic founder mutation BRCA2 999del5: analysis of expression
por: Mikaelsdottir, Evgenia K, et al.
Publicado: (2004)

Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers
por: Jonasson, Jon G, et al.
Publicado: (2016)

BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer
por: Stefansson, Olafur A., et al.
Publicado: (2012)

BRCA1 as a tumor suppressor linked to the regulation of epigenetic states: keeping oncomiRs under control
por: Stefansson, Olafur Andri, et al.
Publicado: (2012)

DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker
por: Heyn, Holger, et al.
Publicado: (2013)

Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors
por: Li, Zidong, et al.
Publicado: (2010)

CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status
por: Gudmundsdottir, K, et al.
Publicado: (2003)

EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells
por: Stefansson, Olafur Andri, et al.
Publicado: (2011)

ARHI is a novel epigenetic silenced tumor suppressor in sporadic pheochromocytoma
por: Wang, Dong, et al.
Publicado: (2017)

A role for BRCA1 in sporadic breast cancer
por: Fraser, J A, et al.
Publicado: (2003)

Methylation of BRCA1 promoter in sporadic breast cancer
por: Jagtap, Sunil Vitthalrao, et al.
Publicado: (2023)

Automated Cancer Diagnostics via Analysis of Optical and Chemical Images by Deep and Shallow Learning
por: Isberg, Olof Gerdur, et al.
Publicado: (2022)

BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers
por: Vos, Shoko, et al.
Publicado: (2017)

BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts
por: Jonsdottir, Asta Björk, et al.
Publicado: (2009)

BRCA1 and BRCA2 Gene Mutations Screening In Sporadic Breast Cancer Patients In Kazakhstan
por: Akilzhanova, Ainur R., et al.
Publicado: (2013)

Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.
por: Beckmann, M. W., et al.
Publicado: (1996)

Editorial: BRCA1 and BRCA2 gene mutations screening in sporadic breast cancer patients in Kazakhstan
por: Jankowitz, Rachel C., et al.
Publicado: (2013)

Contribution of BRCA1 germline mutation in patients with sporadic breast cancer
por: Malik, Fraz A, et al.
Publicado: (2008)

Regulation of BRCA1 expression and its relationship to sporadic breast cancer
por: Mueller, Christopher R, et al.
Publicado: (2003)

BRCA1 Expression Status in Relation to DNA Methylation of the BRCA1 Promoter Region in Sporadic Breast Cancers
por: Niwa, Youko, et al.
Publicado: (2000)

BRCA2 interacting proteins
por: Vidarsson, H, et al.
Publicado: (2000)

Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls
por: van Voss, Marise R Heerma, et al.
Publicado: (2010)

Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
por: Lakhani, Sunil R, et al.
Publicado: (2010)

BRCA1 promoter methylation & its immunohistochemical correlation in sporadic breast cancer
por: Khan, Fatima, et al.
Publicado: (2023)

Lipidomic study of cell lines reveals differences between breast cancer subtypes
por: Eiriksson, Finnur Freyr, et al.
Publicado: (2020)

Mutation Analysis of BRCA1 and BRCA2 in Italian Hereditary and Sporadic Forms of Breast and Ovarian Cancers: Tumor Genotype-Phenotype Correlation in Breast Cancer BRCA-Mutation Carriers
por: Cipollini, G., et al.
Publicado: (1999)

Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer
por: Cox, David G, et al.
Publicado: (2005)

Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological features
por: Rechsteiner, Markus, et al.
Publicado: (2018)

BRCA1 Promoter Methylation and Clinicopathological Characteristics in Sporadic Breast Cancer Patients in Indonesia
por: Harahap, Wirsma Arif, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_397qdoc6iebialvk3s172d8qp6